NOVI Health
Kyle Tan serves as the Chief Product & Business Development Officer at NOVI Health, leading the creation of technology-enhanced solutions for individuals with metabolic diseases since January 2019. In addition to this role, Kyle holds the position of Adjunct Assistant Professor at the Saw Swee Hock School of Public Health, National University of Singapore, starting in December 2017. Previously, Kyle was Deputy Head and Consultant in Preventive Medicine at the National University Health System, where leadership of teams focused on population health strategy and health data analytics occurred. Kyle also has experience as Acting Head of Intermediate and Long Term Care at the same institution and has held previous roles in clinical services, health policy planning, biodefense strategy, and primary care. Educational qualifications include a Master's in Public Health and an M.B.B.S. in Medicine, both from the National University of Singapore.
This person is not in any teams
This person is not in any offices
NOVI Health
NOVI Health is a specialist medical clinic and health-tech company. We provide technology-enhanced clinical solutions for personalised health, diabetes and metabolic diseases. The holistic, data-driven solutions serve not only persons with chronic conditions, but also empowers all for healthier living. NOVI Health enhances the effectiveness of care with an emphasis on precision prevention, by leveraging cutting-edge technology, and state-of-the-art risk profiling. Clients gain real time actionable insights into their body’s response to lifestyle choices and medical treatment. Clients are supported with targeted interventions, tailored to their unique profiles, to help them achieve sustainable healthy habits and improved health outcomes.